These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 9546119)

  • 1. Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication.
    Treiber G; Ammon S; Schneider E; Klotz U
    Helicobacter; 1998 Mar; 3(1):54-8. PubMed ID: 9546119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.
    Laine L; Hunt R; El-Zimaity H; Nguyen B; Osato M; Spénard J
    Am J Gastroenterol; 2003 Mar; 98(3):562-7. PubMed ID: 12650788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.
    Nagahara A; Miwa H; Ogawa K; Kurosawa A; Ohkura R; Iida N; Sato N
    Helicobacter; 2000 Jun; 5(2):88-93. PubMed ID: 10849057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
    Mirbagheri SA; Hasibi M; Abouzari M; Rashidi A
    World J Gastroenterol; 2006 Aug; 12(30):4888-91. PubMed ID: 16937475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
    Lind T; Veldhuyzen van Zanten S; Unge P; Spiller R; Bayerdörffer E; O'Morain C; Bardhan KD; Bradette M; Chiba N; Wrangstadh M; Cederberg C; Idström JP
    Helicobacter; 1996 Sep; 1(3):138-44. PubMed ID: 9398894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
    Nie Y; Li Y; Wu H; Sha W; Du H; Dai S; Wang H; Li Q
    Helicobacter; 1999 Jun; 4(2):128-34. PubMed ID: 10382127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
    Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
    Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
    Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
    Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection.
    Miehlke S; Meining A; Lehn N; Höchter W; Weingart J; Simon T; Krämer W; Klann H; Bolle K; Sommer A; Stolte M; Bayerdörffer E
    Digestion; 1998; 59(6):646-50. PubMed ID: 9813387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
    Wurzer H; Rodrigo L; Stamler D; Archambault A; Rokkas T; Skandalis N; Fedorak R; Bazzoli F; Hentschel E; Mora P; Archimandritis A; Megraud F
    Aliment Pharmacol Ther; 1997 Oct; 11(5):943-52. PubMed ID: 9354205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.
    Gisbert JP; Marcos S; Gisbert JL; Pajares JM
    Helicobacter; 2001 Jun; 6(2):157-62. PubMed ID: 11422472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
    Peitz U; Sulliga M; Wolle K; Leodolter A; Von Arnim U; Kahl S; Stolte M; Börsch G; Labenz J; Malfertheiner P
    Aliment Pharmacol Ther; 2002 Feb; 16(2):315-24. PubMed ID: 11860415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial.
    Xie Y; Pan X; Li Y; Wang H; Du Y; Xu J; Wang J; Zeng Z; Chen Y; Zhang G; Wu K; Liu D; Lv N
    J Antimicrob Chemother; 2018 Jun; 73(6):1681-1687. PubMed ID: 29596646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.